Literature DB >> 30304721

Matrix Gla Protein, Plaque Stability, and Cardiovascular Events in Patients with Severe Atherosclerotic Disease.

Sabine R Zwakenberg1, Yvonne T van der Schouw2, Cees Vermeer3, Gerard Pasterkamp4, Hester M den Ruijter4, Joline W J Beulens2,5.   

Abstract

OBJECTIVE: This study aims to investigate whether plasma matrix Gla protein (MGP) species, desphospho-uncarboxylated (dp-uc) MGP, and total uncarboxylated (t-uc) MGP are associated with plaque levels of uncarboxylated (uc) MGP, markers of plaque stability, and cardiovascular disease (CVD) risk.
METHODS: From the Athero-Express biobank, we selected carotid plaque samples of 100 patients who underwent carotid endarterectomy. The level of agreement between plasma MGP species and plaque ucMGP levels was assessed using weighted kappa (κ). We analyzed histological characteristics of plaque composition (plaque hemorrhage, lipid and calcification content). Logistic regression analyses were used to assess the association between plasma MGP and plaque characteristics. Furthermore, CVD endpoints (n = 20) were collected over a mean follow-up of 2.6 years.
RESULTS: Weighted κ statistics of plasma dp-ucMGP and t-ucMGP and plaque ucMGP were 0.10 (95% CI -0.31 to 0.52) and 0.14 (95% CI -0.20 to 0.48). Higher dp-ucMGP levels tended to be associated with less plaque hemorrhage (ORper 500 nM 0.96; 95% CI 0.92-1.00). No association was found for lipid and calcification content. Cox proportional hazards models showed no association between dp-ucMGP (HRper 200 pM 0.92; 95% CI 0.75-1.11) and an inverse association between t-ucMGP (HRper 500 nM 0.79; 95% CI 0.62-0.99) and cardiovascular events.
CONCLUSIONS: Plasma dp-ucMGP and t-ucMGP concentrations do not reflect plaque ucMGP levels. Elevated dp-ucMGP levels may be associated with less plaque hemorrhage, suggestive of more stable plaques. T-ucMGP was not related with markers of plaque stability; however, elevated plasma t-ucMGP levels were associated with a reduced CVD risk.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiovascular events; Matrix Gla protein; Plaque stability; dp-ucMGP; t-ucMGP

Mesh:

Substances:

Year:  2018        PMID: 30304721      PMCID: PMC6390448          DOI: 10.1159/000493006

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  12 in total

1.  Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans.

Authors:  Roger J M W Rennenberg; Bernard J van Varik; Leon J Schurgers; Karly Hamulyak; Hugo Ten Cate; Tim Leiner; Cees Vermeer; Peter W de Leeuw; Abraham A Kroon
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

2.  Coronary Artery Calcification: A Janus-Faced Biomarker?

Authors:  Chris Reutelingsperger; Leon Schurgers
Journal:  JACC Cardiovasc Imaging       Date:  2017-07-19

3.  Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.

Authors:  Geertje W Dalmeijer; Yvonne T van der Schouw; Cees Vermeer; Elke J Magdeleyns; Leon J Schurgers; Joline W J Beulens
Journal:  J Nutr Biochem       Date:  2012-07-20       Impact factor: 6.048

4.  Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.

Authors:  Yan-Ping Liu; Yu-Mei Gu; Lutgarde Thijs; Marjo H J Knapen; Erika Salvi; Lorena Citterio; Thibault Petit; Simona Delli Carpini; Zhenyu Zhang; Lotte Jacobs; Yu Jin; Cristina Barlassina; Paolo Manunta; Tatiana Kuznetsova; Peter Verhamme; Harry A Struijker-Boudier; Daniele Cusi; Cees Vermeer; Jan A Staessen
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

5.  Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression.

Authors:  D Proudfoot; J N Skepper; C M Shanahan; P L Weissberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-03       Impact factor: 8.311

6.  Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design.

Authors:  Bart A N Verhoeven; Evelyn Velema; Arjan H Schoneveld; Jean Paul P M de Vries; Peter de Bruin; Cees A Seldenrijk; Dominique P V de Kleijn; Els Busser; Yolande van der Graaf; Frans Moll; Gerard Pasterkamp
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species.

Authors:  Ellen C M Cranenburg; Ralf Koos; Leon J Schurgers; Elke J Magdeleyns; Thea H M Schoonbrood; Robert B Landewé; Vincent M Brandenburg; Otto Bekers; Cees Vermeer
Journal:  Thromb Haemost       Date:  2010-08-05       Impact factor: 5.249

8.  The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.

Authors:  Ellen C M Cranenburg; Cees Vermeer; Ralf Koos; Marie-Louise Boumans; Tilman M Hackeng; Freek G Bouwman; Martijn Kwaijtaal; Vincent M Brandenburg; Markus Ketteler; Leon J Schurgers
Journal:  J Vasc Res       Date:  2008-04-10       Impact factor: 1.934

9.  Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients.

Authors:  Ellen C M Cranenburg; Vincent M Brandenburg; Cees Vermeer; Melanie Stenger; Georg Mühlenbruch; Andreas H Mahnken; Ulrich Gladziwa; Markus Ketteler; Leon J Schurgers
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249

10.  Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.

Authors:  Leon J Schurgers; Ivo A Joosen; Eduard M Laufer; Martijn L L Chatrou; Marjolein Herfs; Mark H M Winkens; Ralf Westenfeld; Verena Veulemans; Thilo Krueger; Catherine M Shanahan; Willi Jahnen-Dechent; Erik Biessen; Jagat Narula; Cees Vermeer; Leonard Hofstra; Chris P Reutelingsperger
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more
  6 in total

1.  Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.

Authors:  M Kyla Shea; Kathryn Barger; Sarah L Booth; Gregory Matuszek; Mary Cushman; Emelia J Benjamin; Stephen B Kritchevsky; Daniel E Weiner
Journal:  Am J Clin Nutr       Date:  2020-06-01       Impact factor: 7.045

Review 2.  Serum biomarkers for arterial calcification in humans: A systematic review.

Authors:  Nienke M S Golüke; Marit A Schoffelmeer; Annemarieke De Jonghe; Mariëlle H Emmelot-Vonk; Pim A De Jong; Huiberdina L Koek
Journal:  Bone Rep       Date:  2022-06-18

Review 3.  Vitamin K-Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity.

Authors:  Fang-Fei Wei; Sander Trenson; Peter Verhamme; Cees Vermeer; Jan A Staessen
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 4.  Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.

Authors:  Stefanos Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

Review 5.  Vitamin K2-a neglected player in cardiovascular health: a narrative review.

Authors:  Essa Hariri; Nicholas Kassis; Jean-Pierre Iskandar; Leon J Schurgers; Anas Saad; Omar Abdelfattah; Agam Bansal; Toshiaki Isogai; Serge C Harb; Samir Kapadia
Journal:  Open Heart       Date:  2021-11

Review 6.  Perspective: Evidence before Enthusiasm-A Critical Review of the Potential Cardiovascular Benefits of Vitamin K.

Authors:  M Kyla Shea; Kathleen L Berkner; Guylaine Ferland; Xueyan Fu; Rachel M Holden; Sarah L Booth
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.